Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$605k
2 rounds on record
Latest round
$505k
Convertible Note · Apr 2026 · 5 mo ago
The money's age
Fresh money
5 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 24 Raised a round Convertible Note $505k · SEC Form D Dec 17, 2025 Raised a round Venture round $100k · SEC Form D 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Convertible Note Apr 2026 $505k — SEC Form D
Venture round Dec 2025 $100k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity QENTOROS, INC SEC Form D
Founders and leadersfrom filings, registers and the company's site
Jessica GilbertieExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
Oruka Therapeutics1-10 employees
Who We Are Our Pipeline Overview Presentations and Publications Join Us Investors Overview Press Releases Events & Presentations Stock…
Navigator MedicinesVenture round $10M · 1 mo ago • Founded 2024
Leading the advancement of biologics for targeted immune regulation & restoration.
Find out more about Biodextris, your premier biologics development and manufacturing partner. Check out our cutting-edge solutions.
Alentis TherapeuticsSeries D $181.4M · 23 mo ago • Founded 2019 • 51-200 employees
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
Trellis BioscienceSeries C $9M · 3 mo ago
Trellis Bioscience is developing native human antibodies to disrupt bacterial biofilms and address difficult-to-treat infections.
Halozyme51-200 employees
Together, we are reinventing the patient experience. Elektrofi is now part of Halozyme. Read more here .. By reengineering how medicines…

Overview

Qentoros develops BIO-PLY™ and a growing pipeline of platelet-derived biologics for high-impact equine conditions — clearing infection, calming inflammation, and accelerating tissue healing.

People

Jessica Gilbertie
Executive Officer, Director
Michael Miller
Director
John Schott
Director
Michael Abbott
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Blacksburg United States
HQ
Let's start a conversation
Blacksburg, VA 24060
company site

Financials

Total raised
$605k
Latest round
Convertible Note
Funding rounds
2
Funding rounds
Round Announced Amount
Convertible Note 2026 $505k Details
Venture - Series Unknown 2025 $100k Details